Cytek Biosciences has just seen its modelled fair value trimmed from US$6.00 to about US$5.69, while the average published price target has been reduced from around US$5.50 to about US$4.75.

The Escalating Demand for a Business Insolvency Risk Assessment Given the current economic landscape in the UK—characterized by persistent inflation and post-Brexit market shifts—corporate failure ...

Technology partners can bundle Ziperase data erasure into ServiceNow® offerings, sending compliance evidence instantly ...

New capabilities give infrastructure teams hyperscaler-grade networking (Cloud Routers, Magic Mesh, a stateful Firewall, and VPC Load Balancing) with the visibility, control, and cloud independence to ...

Knox Systems ("Knox"), the largest managed federal cloud provider, today announced a collaboration with Google Public Sector designed to accelerate the delivery of secure commercial software to ...

There is strong interest in the new deep-water foundations, but installing turbines beyond 80-metres water depth is the pinch ...

Creatio CRM delivers a first-rate enterprise-grade business automation framework by blending sales, marketing, and service ...

Transparent pricing offers predictable economics for CBRS operators, new tools reduce transition risk for migrating ...

Strategic co-engineering collaboration helps enterprises move from pilot to production with infrastructure-enforced security, compliance, and lifecycle management — enabling trusted, always-on AI oper ...

Data plaform Databricks is pushing further into the marketing industry with the launch of customer data platform CustomerLake ...

Faraday Future Unveils Full-Form EAI Robot World Spanning Six Product Series, Launches World's First Three-in-One EAI Robotics Education Ecosystem Strategy, and Debuts All-New Futurist Humanoid Robot ...

Android 17 has been in testing since early this year, with the final beta hitting devices just a couple of weeks ago. Insofar ...